Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials

Approximately 20% of cancer clinical trials will never be completed, because they fail to enroll enough participants to be able to answer the research question. Read this white paper to learn the impact that participant payments may play on clinical trial recruitment. 

About the Author

Dr. Lindsay McNair, MD, MPH, MSB | Chief Medical Officer, WCG

Dr. Lindsay McNair has extensive experience in the pharmaceutical industry. Prior to joining WCG, she was a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and study designs for new drug studies, and medical oversight of all phases of clinical trials. Dr. McNair teaches graduate-level courses on the scientific design of clinical research studies. She has been actively involved in IRB work for 18 years, and has a Master’s of Science in Bioethics with a concentration in research ethics.

Follow on Twitter Follow on Linkedin Visit Website More Content by Dr. Lindsay McNair, MD, MPH, MSB | Chief Medical Officer, WCG

No Previous Flipbooks

Next Flipbook
WIRB Institutions Brochure
WIRB Institutions Brochure